EnsoData provides artificial intelligence based software-as-a-service that automates complex, arduous, and time-consuming data analysis for frontline clinicians. Their first product, EnsoSleep, is FDA cleared to automate the scoring of in-lab and home sleep studies and aid clinicians in the diagnosis of sleep disorders like sleep apnea.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/02/18 | $1,500,000 | Seed |
Colle Capital HealthX Ventures M25 Group Sternhill Associates Wisconsin Investment Partners | undisclosed |
| 06/03/22 | $20,000,000 | Series A |
Colle Capital HealthX Ventures Inspire Medical Systems Justin Mortara M25 Group Supermoon Capital Venture Investors Zetta Venture Partners ‹‹Fred Robertson | undisclosed |
